The ruling effectively removes a significant legal overhang surrounding one of the country’s most closely watched public finance disputes, following the eventual return of the P60 billion to PhilHealth.
For stakeholders, the resolution provides greater certainty over the institution’s reserve fund position and the actions taken by its officials during the implementation of government fiscal directives.
Why it matters
PhilHealth sits at the center of the Philippines’ universal health-care system, making confidence in its financial management critical not only for members and health-care providers but also for the broader public sector financing ecosystem.
The Ombudsman said complainants failed to establish prima facie evidence with reasonable certainty of conviction for technical malversation, violations of the Anti-Graft and Corrupt Practices Act, and plunder. Administrative complaints for grave misconduct were also dismissed.
The backdrop
The controversy stemmed from the implementation of Special Provision 1(d) of the 2024 General Appropriations Act and Department of Finance Circular No. 003-2024, which directed the transfer of excess reserve funds from government-owned and controlled corporations to support unprogrammed appropriations.
Under the policy, PhilHealth was directed to transfer P89.9 billion in excess reserve funds to the National Treasury. The state insurer remitted P60 billion in three tranches before the Supreme Court issued a temporary restraining order, leaving P29.9 billion untransferred. The P60 billion has since been restored to PhilHealth.
What the Ombudsman found
The Ombudsman concluded that Recto and Ledesma acted pursuant to laws and regulations that were presumed valid at the time. It also cited their reliance on opinions from the Office of the Government Corporate Counsel, Governance Commission for GOCCs, and Commission on Audit as indicators of good faith.
The resolution noted that the transfer was undertaken in connection with implementing the 2024 budget law before the Supreme Court later ruled against the remittance scheme.
As a result, prosecutors found insufficient basis to establish criminal intent, corruption, bad faith, or personal enrichment.
For PhilHealth, the decision closes another chapter in a dispute that had raised questions about the treatment of reserve funds and the boundaries between fiscal policy and health-care financing, while leaving the state insurer with the returned P60 billion and fewer legal uncertainties surrounding the transaction. —Daxim L. Lucas | Ed: Corrie S. Narisma
